今日盘中，健倍苗苗（02161.HK）股价出现显著上涨，涨幅达5.41%，报2.730港元。这一大幅上涨主要受到公司发布的强劲年度业绩推动。
据悉，健倍苗苗发布了截至2025年3月31日止的年度业绩报告。报告显示，公司在过去一年取得了卓越的经营成果。具体来看，集团收益达到7.82亿港元，同比增长20.65%；公司权益持有人应占溢利更是大幅增长51.2%，达到1.97亿港元。每股盈利为24.08港仙，公司拟派付末期股息每股11.5港仙。
这份亮眼的财报无疑增强了投资者对健倍苗苗未来发展的信心。公司在中药开发、制造及分销领域的优势地位，加上其品牌药和健康保健品业务的稳健发展，为公司的持续增长奠定了坚实基础。市场对这一积极信号做出了迅速反应，推动健倍苗苗股价在盘中显著上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.